Molecular Mechanisms of Toxic Expression Induced by Endocrine Disruptors via AHR
Molecular Mechanisms of Toxic Expression Induced by Endocrine Disruptors via AHR
批准号:
15390040
负责人:
YAMAZAKI Hiroshi
金额:
$8.64万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Polycychc aromatic hydrocarbons (PAHs) which are known as the Environmental Endocrine Disruptors exert the various toxicological effects via aryl hydrocarbon receptor (AHR). However the mechanisms of toxic expression induced by PAHs have not been clarified yet. Therefore, the purpose of this study was to clarify the mechanisms of toxic expression induced by PAHs using differential display method and DNA microarray method. First, total RNA were prepared from the wild type mouse and AHR knock out mouse livers treated. with 3-methylcholanthrene (MC). We found the novel AHR target genes using differential display method and DNA microarray method. Interestingly, the mRNA expressions of the peroxisome prolifilator-activated receptor (PPAR) α target genes were suppressed by PAH treatment through AHR. We also demonstrated that AHR inhibited PPARα signals through the suppression of its heterodimeric partner, retinoid X receptor (RXR)α. The genes responsible for the fatty acid metabolism were regulated by PPARα. Therefore, it was suggested that the suppression of the PPARα signal was important for the occurrence of fatty liver.
期刊论文(44)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Toide K, Yamazaki H, et al.: "Aryl hydrocarbon hydroxylase represents CYP1B1, and not CYP1A1, in human freshly isolated white cells"Cancer Epidem Biomarker Prev. 12. 219-222 (2003)
Toide K、Yamazaki H 等人:“在人类新鲜分离的白细胞中,芳基烃羟化酶代表 CYP1B1,而不是 CYP1A1”Cancer Epidem Biomarker Prev.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Toide K, Yamazaki H, Kamataki T: "Reply : Correspondence re : K.Toide et al."Cancer Epidem Biomarker Prev. 12. 1118 (2003)
Toide K、Yamazaki H、Kamataki T:“回复:通讯:K.Toide 等人”Cancer Epidem Biomarker Prev。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.1016/j.mrgentox.2004.06.003
发表时间:
2004-08
期刊:
Mutation research
影响因子:
--
作者:
[Y. Yamazaki;Ken-Ichi Fujita;K. Nakayama;A. Suzuki;Katsunori Nakamura;H. Yamazaki;T. Kamataki]
通讯作者:
Y. Yamazaki;Ken-Ichi Fujita;K. Nakayama;A. Suzuki;Katsunori Nakamura;H. Yamazaki;T. Kamataki
DOI:
10.1124/mol.65.2.326
发表时间:
2004-02-01
期刊:
MOLECULAR PHARMACOLOGY
影响因子:
3.6
作者:
[Matsumura, K, Saito, T, Kamataki, T]
通讯作者:
Kamataki, T
DOI:
10.2133/dmpk.19.120
发表时间:
2004-04-01
期刊:
Drug metabolism and pharmacokinetics
影响因子:
2.1
作者:
[Yamaori, Satoshi, Yamazaki, Hiroshi, Kamataki, Tetsuya]
通讯作者:
Kamataki, Tetsuya
共 13 条
Relevance to bioactivation and toxicity of thalidomide, pomalidomide, and lenalidomide by human cytochrome P450 3A enzymes in cultured placental cells and humanized-liver mice
-
批准号:17K08425
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2017
-
负责人:YAMAZAKI Hiroshi
-
依托单位:
Mechanisms of resistance to molecularly targeted drugs for oral squamous cell carcinoma and investigation of countermeasures
-
批准号:16K11732
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2016
-
负责人:YAMAZAKI Hiroshi
-
依托单位:
Development of Effective Markers for Resistance of Oral Squamous Cell Carcinoma to Molecular-targeting Drugs
-
批准号:25463120
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2013
-
负责人:YAMAZAKI Hiroshi
-
依托单位:
Thalidomide increases cytochrome P450 activity and drug metabolism in liver through direct activation of nuclear receptor CAR and PXR
-
批准号:23590200
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.49万
-
财政年份:2011
-
负责人:YAMAZAKI Hiroshi
-
依托单位:
evaluationofeffectivenessoftheobjectiveexaminationforautism indeafchildren
-
批准号:22791642
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.5万
-
财政年份:2010
-
负责人:YAMAZAKI Hiroshi
-
依托单位:
Role of cancer stem cells related molecules in oral squamous cell carcinoma
-
批准号:22592246
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2010
-
负责人:YAMAZAKI Hiroshi
-
依托单位:
Molecular mechanism of chemical-induced toxicity in fetal livers
-
批准号:17390034
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.07万
-
财政年份:2005
-
负责人:YAMAZAKI Hiroshi
-
依托单位:
Study on the separation of rac and meso isomers and the reactivity of group 4 bridged metallocene complexes
-
批准号:11640544
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$0.38万
-
财政年份:1999
-
负责人:YAMAZAKI Hiroshi
-
依托单位:
PREDICTION OF DRUG DISPOSITION BY HUMAN DRUG METABOLIZING ENZYMES
-
批准号:11557191
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$3.01万
-
财政年份:1999
-
负责人:YAMAZAKI Hiroshi
-
依托单位:
Creation of Substitution Labile Pyrazolylborate Metal Complexes
-
批准号:09640675
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$0.96万
-
财政年份:1997
-
负责人:YAMAZAKI Hiroshi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
病毒辅助代谢基因调控宿主群落促进
HMW-PAHs降解的作用及机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:朱爽
-
依托单位:
珠江口水环境DOM分子组成对PAHs相关微
生物代谢的影响机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:林慰
-
依托单位:
基于特征组分解析的废矿物油热解过程PAHs生成研究
-
批准号:JCZRQN202500291
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
基于三重同位素示踪技术的大气MW302 PAHs来源解析
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:曾源
-
依托单位:
环境混合PAHs暴露通过电子传递链复合物亚基SDH诱导质粒介导ARGs接合转移的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2024
-
负责人:邹慧云
-
依托单位:
肠道菌群调节PAHs毒性研究:基于色氨酸代谢物与AhR的交互作用
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
基于AhR活性指示大气细颗粒物中的PAHs致血管老化的机制及剂效-关系研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:范瑞芳
-
依托单位:
多环芳烃(PAHs )介导的癌细胞和Th17细胞“cross-talk”所
致免疫抑制反应在胶质瘤增殖侵袭中的作用及毒理学机制研
究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
PM2.5毒性组分PAHs暴露与儿童肺功能损伤的相关性及DNA甲基化
调控机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:曾志俊
-
依托单位:
碳减排对土壤PAHs污染效应的影响研究
-
批准号:42307002
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:汪伟伟
-
依托单位: